JP2022164822A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022164822A5 JP2022164822A5 JP2022137773A JP2022137773A JP2022164822A5 JP 2022164822 A5 JP2022164822 A5 JP 2022164822A5 JP 2022137773 A JP2022137773 A JP 2022137773A JP 2022137773 A JP2022137773 A JP 2022137773A JP 2022164822 A5 JP2022164822 A5 JP 2022164822A5
- Authority
- JP
- Japan
- Prior art keywords
- zfn
- nuclease
- seq
- composition
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024017157A JP2024036610A (ja) | 2017-06-16 | 2024-02-07 | Ｔ細胞および／またはｈｌａ受容体の標的化破壊 |
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762521132P | 2017-06-16 | 2017-06-16 | |
| US62/521,132 | 2017-06-16 | ||
| US201762542052P | 2017-08-07 | 2017-08-07 | |
| US62/542,052 | 2017-08-07 | ||
| US201762573956P | 2017-10-18 | 2017-10-18 | |
| US62/573,956 | 2017-10-18 | ||
| JP2019568660A JP7419073B2 (ja) | 2017-06-16 | 2018-06-15 | Ｔ細胞および／またはｈｌａ受容体の標的化破壊 |
| PCT/US2018/037844 WO2018232296A1 (en) | 2017-06-16 | 2018-06-15 | Targeted disruption of t cell and/or hla receptors |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019568660A Division JP7419073B2 (ja) | 2017-06-16 | 2018-06-15 | Ｔ細胞および／またはｈｌａ受容体の標的化破壊 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024017157A Division JP2024036610A (ja) | 2017-06-16 | 2024-02-07 | Ｔ細胞および／またはｈｌａ受容体の標的化破壊 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022164822A JP2022164822A (ja) | 2022-10-27 |
| JP2022164822A5 true JP2022164822A5 (enExample) | 2023-09-19 |
| JP7482176B2 JP7482176B2 (ja) | 2024-05-13 |
Family
ID=64656803
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019568660A Active JP7419073B2 (ja) | 2017-06-16 | 2018-06-15 | Ｔ細胞および／またはｈｌａ受容体の標的化破壊 |
| JP2022137773A Active JP7482176B2 (ja) | 2017-06-16 | 2022-08-31 | Ｔ細胞および／またはｈｌａ受容体の標的化破壊 |
| JP2024017157A Pending JP2024036610A (ja) | 2017-06-16 | 2024-02-07 | Ｔ細胞および／またはｈｌａ受容体の標的化破壊 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019568660A Active JP7419073B2 (ja) | 2017-06-16 | 2018-06-15 | Ｔ細胞および／またはｈｌａ受容体の標的化破壊 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024017157A Pending JP2024036610A (ja) | 2017-06-16 | 2024-02-07 | Ｔ細胞および／またはｈｌａ受容体の標的化破壊 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230295563A1 (enExample) |
| EP (1) | EP3638783A4 (enExample) |
| JP (3) | JP7419073B2 (enExample) |
| KR (1) | KR102708624B1 (enExample) |
| CN (1) | CN110997913B (enExample) |
| AU (1) | AU2018283310B2 (enExample) |
| BR (1) | BR112019026622A2 (enExample) |
| CA (1) | CA3066641A1 (enExample) |
| IL (1) | IL271298A (enExample) |
| SG (1) | SG11201911729SA (enExample) |
| WO (1) | WO2018232296A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3051113A1 (en) * | 2017-01-26 | 2018-08-02 | Sangamo Therapeutics, Inc. | B-cell engineering |
| JP2022500052A (ja) * | 2018-09-18 | 2022-01-04 | サンガモ セラピューティクス， インコーポレイテッド | プログラム細胞死１（ｐｄ１）特異的ヌクレアーゼ |
| WO2022094154A1 (en) | 2020-10-28 | 2022-05-05 | Sangamo Therapeutics, Inc. | Generation of cd4+ effector and regulatory t cells from human pluripotent stem cells |
| CN113846070B (zh) * | 2021-10-18 | 2023-05-16 | 翌圣生物科技(上海)股份有限公司 | 高活性的mTET2酶突变体、其编码DNA及其应用 |
| CN118813625B (zh) * | 2024-06-17 | 2025-08-26 | 天海元祺生物科技(天津)有限公司 | 高度靶向人类HLA-A基因的sgRNA及应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1618218A2 (en) * | 2003-04-29 | 2006-01-25 | Wyeth | Methods for prognosis and treatment of solid tumors |
| US8791324B2 (en) * | 2008-04-21 | 2014-07-29 | Danziger Innovations Ltd. | Plant viral expression vectors and use of same for generating genotypic variations in plant genomes |
| JP5955871B2 (ja) * | 2011-03-17 | 2016-07-20 | ミルテニイ バイオテック ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｔｃｒアルファ／ベータを枯渇させた細胞調製物 |
| WO2012127464A2 (en) * | 2011-03-23 | 2012-09-27 | Gavish-Galilee Bio Applications Ltd | Constitutively activated t cells for use in adoptive cell therapy |
| EP3591045B1 (en) * | 2013-08-28 | 2024-07-17 | Sangamo Therapeutics, Inc. | Compositions for linking dna-binding domains and cleavage domains |
| KR102228828B1 (ko) * | 2014-03-11 | 2021-03-16 | 셀렉티스 | 동종이형 이식에 양립성인 t-세포들을 만들어내는 방법 |
| CN107405411A (zh) * | 2014-05-01 | 2017-11-28 | 华盛顿大学 | 使用腺病毒载体的体内基因改造 |
| AU2016291778B2 (en) * | 2015-07-13 | 2021-05-06 | Sangamo Therapeutics, Inc. | Delivery methods and compositions for nuclease-mediated genome engineering |
| KR20180088911A (ko) * | 2015-12-18 | 2018-08-07 | 상가모 테라퓨틱스, 인코포레이티드 | Mhc 세포 수용체의 표적화된 붕괴 |
| WO2017106528A2 (en) * | 2015-12-18 | 2017-06-22 | Sangamo Biosciences, Inc. | Targeted disruption of the t cell receptor |
| IL272302B2 (en) * | 2017-08-08 | 2025-01-01 | Sangamo Therapeutics Inc | Targeting T cells with genetic modifications mediated by a chimeric antigen receptor |
| RU2020129448A (ru) * | 2018-02-08 | 2022-03-09 | Сангамо Терапьютикс, Инк. | Сконструированные специфические для мишени нуклеазы |
-
2018
- 2018-06-15 BR BR112019026622-4A patent/BR112019026622A2/pt not_active IP Right Cessation
- 2018-06-15 KR KR1020207000964A patent/KR102708624B1/ko active Active
- 2018-06-15 CA CA3066641A patent/CA3066641A1/en active Pending
- 2018-06-15 AU AU2018283310A patent/AU2018283310B2/en not_active Expired - Fee Related
- 2018-06-15 JP JP2019568660A patent/JP7419073B2/ja active Active
- 2018-06-15 WO PCT/US2018/037844 patent/WO2018232296A1/en not_active Ceased
- 2018-06-15 EP EP18818351.1A patent/EP3638783A4/en active Pending
- 2018-06-15 CN CN201880052991.4A patent/CN110997913B/zh active Active
- 2018-06-15 SG SG11201911729SA patent/SG11201911729SA/en unknown
-
2019
- 2019-12-10 IL IL271298A patent/IL271298A/en unknown
-
2022
- 2022-08-31 JP JP2022137773A patent/JP7482176B2/ja active Active
- 2022-10-21 US US17/971,071 patent/US20230295563A1/en active Pending
-
2024
- 2024-02-07 JP JP2024017157A patent/JP2024036610A/ja active Pending